Clinical Trial Update: A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for a cell therapy in COVID-19 patients with acute kidney injury on renal replacement therapy, spanning Phase 1 and Phase 2, current sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Cell Therapy (Sentien Biotechnologies subject to further details in trial)

Snippet

Sponsor: Sentien Biotechnologies, Inc. | Conditions: COVID-19, Acute Kidney Injury | Phase 1, Phase 2 | Status: UNKNOWN